Company research
NKGen Biotech, Inc.
CIK 1845459Updated Sep 26, 2026
SecuritiesNKGN · OTC · equityNKGNW · OTC · warrant
Name history
Graf Acquisition Corp. IV · through Sep 29, 2023
NKGN price & chart
Loading TradingView…
OTC:NKGN on TradingView ↗In the news
NKGen Biotech to Present on Potential of Troculeucel in Neurodegenerative Diseases at Biologics Manufacturing Korea 2026 ↗
Recent filings
Entry into a Material Definitive Agreement · Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement · Unregistered Sales of Equity Securities
Items 1.01, 2.03, 3.02, 9.01
Entry into a Material Definitive Agreement
Items 1.01, 9.01
Entry into a Material Definitive Agreement · Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement · Unregistered Sales of Equity Securities
Items 1.01, 2.03, 3.02, 9.01
Entry into a Material Definitive Agreement · Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement · Unregistered Sales of Equity Securities
Items 1.01, 2.03, 3.02, 9.01
Entry into a Material Definitive Agreement · Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement · Unregistered Sales of Equity Securities
Items 1.01, 2.03, 3.02, 9.01
Show 1 more recent filings
Financials
FY 2024 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 16,231,000Source | 16,481,000Source | 174,366,108Source | 174,191,383Source |
| Property, Plant and Equipment, NetUSD | 13,297,000Source | 14,459,000Source | 15,521,000Source | — |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 106,000Source | 26,000Source | 635,155Source | 1,722,506Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | — | 0Source | — | — |
| Assets, CurrentUSD | 2,459,000Source | 1,930,000Source | 877,907Source | 2,535,230Source |
| Prepaid Expense and Other Assets, CurrentUSD | 2,224,000Source | 1,654,000Source | — | — |
| Operating Lease, Right-of-Use AssetUSD | 379,000Source | 0Source | — | — |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 86,139,000Source | 75,174,000Source | 5,372,812Source | 13,471,084Source |
| Stockholders’ equity: | ||||
| Common Stock, Value, IssuedUSD | 4,000Source | 2,000Source | — | 429Source |
| Additional Paid in CapitalUSD | 136,686,000Source | 121,727,000Source | 0Source | — |
| Retained Earnings (Accumulated Deficit)USD | -206,416,000Source | -162,130,000Source | -4,171,255Source | -10,895,130Source |
| Stockholders' Equity Attributable to ParentUSD | -69,908,000Source | -58,693,000Source | -4,170,826Source | -10,894,701Source |
| Liabilities and EquityUSD | 16,231,000Source | 16,481,000Source | 174,366,108Source | 174,191,383Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 57,971,000Source | 39,452,000Source | 2,845,588Source | 1,893,149Source |
| Operating Lease, Liability, CurrentUSD | 154,000Source | 0Source | — | — |
| Accounts Payable, CurrentUSD | 14,391,000Source | 11,040,000Source | 177,157Source | 51,807Source |
| Operating Lease, Liability, NoncurrentUSD | 246,000Source | — | — | — |
| Deferred Income Tax Liabilities, NetUSD | 8,000Source | 33,000Source | — | — |
| Additional Financial Items | ||||
| Accounts Receivable, after Allowance for Credit LossUSD | — | 0Source | — | — |
| Accrued Liabilities, CurrentUSD | 460,000Source | 1,360,000Source | 2,444,352Source | 1,656,137Source |
| Deferred Tax Liabilities, NetUSD | 8,000Source | 33,000Source | — | — |
cash flow · annual statements
| Line item | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | — | — | 4,548,351Source | -990,638Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation, Depletion and AmortizationUSD | 1,181,000Source | 1,203,000Source | — | — |
| Share-based Payment Arrangement, Noncash ExpenseUSD | 4,142,000Source | 4,135,000Source | — | — |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts ReceivableUSD | 0Source | -29,000Source | — | — |
| Increase (Decrease) in Accounts PayableUSD | — | — | 125,350Source | 51,807Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -20,881,000Source | -21,948,000Source | -1,570,993Source | -1,523,725Source |
| Cash flows from investing activities: | ||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | -13,000Source | -48,000Source | 568,642Source | -171,615,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | — | 0Source | — | — |
| Cash flows from financing activities: | ||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 20,853,000Source | 22,155,000Source | -85,000Source | 174,861,231Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | -41,000Source | 159,000Source | -1,087,351Source | 1,722,506Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 235,000Source | 276,000Source | 635,155Source | 1,722,506Source |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 953,000Source | 241,000Source | — | — |
| Income Taxes Paid, NetUSD | — | — | 257,000Source | — |
| Additional Financial Items | ||||
| Share-based Payment Arrangement, ExpenseUSD | 4,142,000Source | 4,135,000Source | — | — |
| DepreciationUSD | 1,200,000Source | 1,100,000Source | — | — |
| Gain (Loss) on Sale of DerivativesUSD | — | -24,475,000Source | — | — |
| Gain (Loss) on Disposition of Property Plant EquipmentUSD | -9,000Source | — | — | — |
| General and Administrative ExpenseUSD | 16,310,000Source | 14,078,000Source | 2,390,889Source | 2,214,615Source |
| Income Tax Expense (Benefit)USD | 53,000Source | 7,000Source | 438,374Source | — |
| InterestExpenseNonoperatingUSD | 2,724,000Source | — | — | — |
| Investment Income, InterestUSD | — | — | 2,400,690Source | 41,153Source |
| Net Income (Loss) Attributable to ParentUSD | -44,286,000Source | -82,954,000Source | 4,548,351Source | -990,638Source |
| Nonoperating Income (Expense)USD | -17,267,000Source | — | 7,726,755Source | 1,517,569Source |
| Other Nonoperating Income (Expense)USD | -6,000Source | 120,000Source | — | — |
| Proceeds from Contributed CapitalUSD | 3,107,000Source | — | — | — |
| Proceeds from Issuance of Common StockUSD | 100,000Source | 1,668,000Source | — | — |
| Proceeds from Stock Options ExercisedUSD | 0Source | 12,000Source | — | — |
| Unrealized Gain (Loss) on DerivativesUSD | — | -9,784,000Source | — | — |
income statement · annual statements
| Line item | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|
| Total RevenueUSD | — | 0Source | — | — |
| Cost of Goods and Services Sold | — | — | — | — |
| Gross Profit (Calculated) · Derived | — | — | — | — |
| Operating Income (Loss)USD | -26,966,000Source | -29,746,000Source | -2,740,030Source | -2,508,207Source |
| Other Nonoperating Income (Expense)USD | -6,000Source | 120,000Source | — | — |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | — | -82,947,000Source | 4,986,725Source | — |
| Income Tax Expense (Benefit)USD | 53,000Source | 7,000Source | 438,374Source | — |
| Net Income (Loss) Attributable to ParentUSD | -44,286,000Source | -82,954,000Source | 4,548,351Source | -990,638Source |
| Earnings Per Share, BasicUSD per share | -1.54Source | -5.38Source | 0.21Source | -0.07Source |
| Earnings Per Share, DilutedUSD per share | -1.54Source | -5.38Source | 0.39Source | -0.07Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 28,830,356Source | 15,426,908Source | 21,451,875Source | 15,083,469Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 28,830,356Source | 15,426,908Source | 21,451,875Source | 15,083,469Source |
| Interest Expense (non-operating)USD | 2,724,000Source | — | — | — |
| Additional Financial Items | ||||
| Costs and ExpensesUSD | 26,966,000Source | 29,746,000Source | — | — |
| General and Administrative ExpenseUSD | 16,310,000Source | 14,078,000Source | 2,390,889Source | 2,214,615Source |
| Income (Loss) Attributable to Parent, before TaxUSD | -44,233,000Source | — | — | — |
| Interest ExpenseUSD | — | 745,000Source | — | — |
| Investment Income, InterestUSD | — | — | 2,400,690Source | 41,153Source |
| Nonoperating Income (Expense)USD | -17,267,000Source | — | 7,726,755Source | 1,517,569Source |
| Research and Development ExpenseUSD | 10,656,000Source | 15,668,000Source | — | — |